perindopril has been researched along with Kidney Diseases in 30 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (3.33) | 18.7374 |
| 1990's | 5 (16.67) | 18.2507 |
| 2000's | 15 (50.00) | 29.6817 |
| 2010's | 7 (23.33) | 24.3611 |
| 2020's | 2 (6.67) | 2.80 |
| Authors | Studies |
|---|---|
| Cooper, ME; Knudsen, ST | 1 |
| Aljuhani, N; El-Awady, MS; Hassan, MH; Ismail, RS | 1 |
| Chalmers, J; Coresh, J; Herrington, W; Li, Q; Mancia, G; Marre, M; Mohammedi, K; Perkovic, V; Poulter, N; Rodgers, A; Williams, B; Woodward, M | 1 |
| Abd El-Ghany, AA; Hassan, MIA; Shalkami, AS | 1 |
| Sharma, K; Sweiss, N | 1 |
| Cheung, CS; Griffiths, SM; Leeder, SR; Tam, WW; Wang, HH; Wong, MC; Yan, BP; Zhang, D | 1 |
| Dijoud, F; Egan, EJ; Gilibert, S; Sassard, J | 1 |
| Liu, X; Ning, W; Tao, L; Xu, H | 1 |
| Le Jeune, S; Mourad, JJ | 1 |
| Buniatian, ND; Lednev, OA; Lukashev, AM; Sergeev, SV; Zaslavskaia, RM | 1 |
| Aleksandrowicz-Wrona, E; Heleniak, Z; Lizakowski, S; Małgorzewicz, S; Renke, M; Rutkowski, B; Rutkowski, P; Sławińska-Morawska, M; Tylicki, L | 1 |
| Beckett, N; Bulpitt, C; Burch, L; Fagard, R; Fletcher, A; Li, M; Narkiewicz, K; Nitsch, D; Peters, R; Poulter, R; Wang, N | 1 |
| Bertram, D; Blanc-Brunat, N; Lo, M; Sassard, J | 1 |
| Andrejak, M; Fournier, A; Godefroy, O; Oprisiu, R; Slama, M | 1 |
| Cox, AJ; Gilbert, RE; Hepper, C; Kelly, DJ; Wu, LL | 1 |
| Mogensen, CE | 1 |
| Waeber, B | 1 |
| Brezniceanu, ML; Chan, JS; Filep, JG; Guo, DF; Hamet, P; Hsieh, TJ; Ingelfinger, JR; Liu, F; Liu, Q; Sachetelli, S; Sigmund, CD; Zhang, SL | 1 |
| Cox, AJ; Gilbert, RE; Kelly, DJ; Zhang, Y | 1 |
| Cohen, R; Emonnot, L; Lo, M | 1 |
| Cooper, ME; Doyle, AE; Rumble, JR | 1 |
| Bönner, G; Lederle, RM; Scholze, J; Stumpe, KO | 1 |
| Overlack, A; Stumpe, KO | 1 |
| Delaney, KH; Kwiecien, JM; Lee, RM; Smeda, JS; Wang, H | 1 |
| el-Shahawy, M; Khwaja, S; Massry, SG; Nosrati, SM | 1 |
| Bianchetti, MG; Meregalli, P; Mozzettini, S; Ramelli, GP; Truttmann, AC; von Vigier, RO | 1 |
| Gouyon, JB; Guignard, JP; Justrabo, E; Prévot, A; Semama, DS; Tendron, A | 1 |
| Hoy, W | 1 |
| Cheer, SM; Goa, KL; Matheson, AJ | 1 |
| Borghi, H; Fillastre, JP; Morin, JP; Thomas, N; Toutain, H | 1 |
5 review(s) available for perindopril and Kidney Diseases
| Article | Year |
|---|---|
Renal protection: What have we learnt from ADVANCE about kidney disease in type 2 diabetes?
Topics: Antihypertensive Agents; Diabetes Mellitus, Type 2; Humans; Hypertension; Hypoglycemic Agents; Indapamide; Kidney Diseases; Observational Studies as Topic; Perindopril; Randomized Controlled Trials as Topic | 2020 |
Adiponectin effects on the kidney.
Topics: Adiponectin; Albuminuria; Amlodipine; AMP-Activated Protein Kinases; Animals; Benzimidazoles; Benzoates; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Disease Progression; Humans; Kidney; Kidney Diseases; Mice; Obesity; Oxidative Stress; Perindopril; Renal Insufficiency, Chronic; Telmisartan | 2014 |
Evaluation of high dose of perindopril/indapamide fixed combination in reducing blood pressure and improving end-organ protection in hypertensive patients.
Topics: Antihypertensive Agents; Blood Pressure; Cytoprotection; Dose-Response Relationship, Drug; Drug Combinations; Humans; Hypertension; Indapamide; Kidney; Kidney Diseases; Perindopril; Randomized Controlled Trials as Topic; Titrimetry; Treatment Outcome | 2009 |
Renal disease in Australian Aborigines.
Topics: Angiotensin-Converting Enzyme Inhibitors; Australia; Cardiovascular Diseases; Health Services; Humans; Kidney; Kidney Diseases; Native Hawaiian or Other Pacific Islander; Perindopril | 2000 |
Perindopril/indapamide 2/0.625 mg/day: a review of its place in the management of hypertension.
Topics: Adult; Age Factors; Aged; Animals; Antihypertensive Agents; Blood Pressure; Disease Models, Animal; Humans; Hypertension; Hypertrophy, Left Ventricular; Hypokalemia; Indapamide; Kidney Diseases; Middle Aged; Perindopril; Randomized Controlled Trials as Topic | 2001 |
6 trial(s) available for perindopril and Kidney Diseases
| Article | Year |
|---|---|
Associations between body mass index and the risk of renal events in patients with type 2 diabetes.
Topics: Aged; Albuminuria; Blood Glucose; Body Mass Index; Creatinine; Diabetes Mellitus, Type 2; Drug Combinations; Female; Follow-Up Studies; Humans; Hypoglycemic Agents; Indapamide; Kidney; Kidney Diseases; Male; Middle Aged; Obesity; Overweight; Perindopril; Reference Values; Renal Insufficiency | 2018 |
Aliskiren and perindopril reduce the levels of transforming growth factor-β in patients with non-diabetic kidney disease.
Topics: Adult; Amides; Antihypertensive Agents; Chronic Disease; Creatinine; Cross-Over Studies; Double-Blind Method; Female; Fibrosis; Fumarates; Humans; Kidney; Kidney Diseases; Male; Peptide Fragments; Perindopril; Pilot Projects; Procollagen; Renin; Transforming Growth Factor beta; Treatment Outcome | 2012 |
Kidney function in the very elderly with hypertension: data from the hypertension in the very elderly (HYVET) trial.
Topics: Age Factors; Aged, 80 and over; Aging; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Delayed-Action Preparations; Diuretics; Drug Therapy, Combination; Female; Glomerular Filtration Rate; Heart Failure; Humans; Hypertension; Indapamide; Kidney; Kidney Diseases; Male; Perindopril; Proportional Hazards Models; Proteinuria; Risk Assessment; Risk Factors; Time Factors; Treatment Outcome | 2013 |
Therapeutic safety of perindopril in the treatment of mild hypertension with concomitant nephropathy.
Topics: Adult; Aged; Albuminuria; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Double-Blind Method; Female; Humans; Hypertension, Renal; Indoles; Kidney Diseases; Kidney Function Tests; Male; Middle Aged; Perindopril | 1993 |
A new trial of the efficacy, tolerability, and safety of angiotensin-converting enzyme inhibition in mild systemic hypertension with concomitant diseases and therapies. Perindopril Therapeutic Safety Study Group (PUTS).
Topics: Adult; Aged; Angina Pectoris; Angiotensin-Converting Enzyme Inhibitors; Anti-Inflammatory Agents, Non-Steroidal; Diabetes Mellitus, Type 2; Double-Blind Method; Female; Humans; Hyperlipidemias; Hypertension; Indoles; Kidney Diseases; Male; Middle Aged; Perindopril; Proteinuria; Treatment Outcome | 1993 |
Effect of angiotensin converting enzyme inhibition by perindopril on proteinuria of primary renal diseases.
Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Double-Blind Method; Female; Humans; Indoles; Kidney Diseases; Male; Middle Aged; Perindopril; Proteinuria; Serum Albumin; Sodium; Treatment Outcome | 1997 |
19 other study(ies) available for perindopril and Kidney Diseases
| Article | Year |
|---|---|
Modulatory effects of perindopril on cisplatin-induced nephrotoxicity in mice: Implication of inflammatory cytokines and caspase-3 mediated apoptosis.
Topics: Albuminuria; Angiotensin-Converting Enzyme Inhibitors; Animals; Antineoplastic Agents; Antioxidants; Apoptosis; Apoptosis Regulatory Proteins; Caspase 3; Cisplatin; Cytokines; Inflammation; Kidney Diseases; Kidney Function Tests; Lipid Peroxidation; Male; Mice; Oxidative Stress; Perindopril | 2020 |
Perindopril regulates the inflammatory mediators, NF-κB/TNF-α/IL-6, and apoptosis in cisplatin-induced renal dysfunction.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Apoptosis; Caspase 3; Cisplatin; Interleukin-6; Kidney; Kidney Diseases; Male; NF-kappa B; Oxidative Stress; Perindopril; Rats; Tumor Necrosis Factor-alpha | 2018 |
The effectiveness of perindopril vs. lisinopril on reducing the incidence of diabetes and renal diseases: A cohort study of 20,252 patients.
Topics: Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Cohort Studies; Diabetes Mellitus; Female; Hong Kong; Humans; Incidence; Kidney Diseases; Lisinopril; Male; Middle Aged; Perindopril; Treatment Outcome | 2015 |
Renoprotection persists after cessation of treatment with very low doses of perindopril in Lyon hypertensive rats.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Blood Pressure; Hypertension; Kidney; Kidney Diseases; Kidney Function Tests; Male; Perindopril; Proteinuria; Rats | 2008 |
[Expression of HIF-1alpha in 5/6-nephrectomized rat models of chronic kidney fibrosis].
Topics: Animals; Connective Tissue Growth Factor; Fibrosis; Hypoxia-Inducible Factor 1, alpha Subunit; Kidney; Kidney Diseases; Male; Nephrectomy; Perindopril; Random Allocation; Rats; Rats, Sprague-Dawley; RNA, Messenger | 2009 |
[Efficacy of traditional therapy and chronotherapy using prestarium in elderly patients with polymorbid syndrome].
Topics: Aged; Aged, 80 and over; Angiotensin-Converting Enzyme Inhibitors; Diabetes Mellitus; Drug Chronotherapy; Female; Humans; Hypertension; Kidney Diseases; Male; Middle Aged; Perindopril; Renal Insufficiency, Chronic; Syndrome | 2010 |
Differential evolution of blood pressure and renal lesions after RAS blockade in Lyon hypertensive rats.
Topics: Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Diuresis; Glomerulosclerosis, Focal Segmental; Hypertension, Renal; Kidney; Kidney Diseases; Losartan; Male; Natriuresis; Perindopril; Proteinuria; Rats; Receptor, Angiotensin, Type 1; Renin-Angiotensin System | 2002 |
Converting enzyme inhibitor or AT1-receptor blocker for decreasing long-term mortality in patients with stroke history and renal dysfunction?
Topics: Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Clinical Trials as Topic; Humans; Indapamide; Kidney Diseases; Perindopril; Ramipril; Receptor, Angiotensin, Type 1; Stroke | 2003 |
Vascular endothelial growth factor expression and glomerular endothelial cell loss in the remnant kidney model.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Cell Count; Disease Models, Animal; Endothelial Growth Factors; Endothelium, Vascular; Gene Expression; In Situ Hybridization; Kidney Diseases; Kidney Glomerulus; Male; Perindopril; Rats; Rats, Sprague-Dawley; Vascular Endothelial Growth Factor A | 2003 |
[Vascular impact of anti-hypertensive treatment and renal protection].
Topics: Albuminuria; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Diuretics; Double-Blind Method; France; Humans; Hypertension; Indapamide; Kidney Diseases; Perindopril | 2005 |
What can be learned from the experience with the fixed low-dose combination of perindopril/indapamide in the treatment of hypertension?
Topics: Administration, Oral; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Diabetes Mellitus, Type 2; Diuretics; Drug Administration Schedule; Drug Combinations; Heart Diseases; Humans; Hypertension; Indapamide; Kidney Diseases; Perindopril | 2005 |
RAS blockade decreases blood pressure and proteinuria in transgenic mice overexpressing rat angiotensinogen gene in the kidney.
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Angiotensinogen; Animals; Blood Pressure; Blotting, Western; DNA, Complementary; Female; Gene Expression Regulation; Hypertension; Immunohistochemistry; Kidney; Kidney Diseases; Losartan; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Perindopril; Proteins; Proteinuria; Rats; Renin-Angiotensin System | 2006 |
Combination therapy with tranilast and angiotensin-converting enzyme inhibition provides additional renoprotection in the remnant kidney model.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Disease Models, Animal; Drug Therapy, Combination; Fibrosis; Kidney; Kidney Diseases; Male; ortho-Aminobenzoates; Perindopril; Rats; Rats, Sprague-Dawley | 2006 |
Renal and metabolic disorders depend on the renin-angiotensin system in Lyon hypertensive rats associated with diabetes.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Diabetes Mellitus, Experimental; Hyperlipidemias; Hypertension; Kidney Diseases; Male; Perindopril; Proteinuria; Rats; Renin-Angiotensin System | 2008 |
Comparison of effects of ACE inhibition with calcium channel blockade on renal disease in a model combining genetic hypertension and diabetes.
Topics: Albuminuria; Animals; Blood Glucose; Blood Pressure; Body Weight; Diabetes Mellitus, Experimental; Dihydropyridines; Disease Models, Animal; Hypertension; Indoles; Kidney Diseases; Male; Perindopril; Random Allocation; Rats; Rats, Inbred SHR; Renin | 1995 |
Prevention of stroke with perindopril treatment in stroke-prone spontaneously hypertensive rats.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Blood Pressure; Body Weight; Brain; Cerebral Cortex; Cerebrovascular Disorders; Heart Rate; Hypertension; Indoles; Kidney; Kidney Diseases; Male; Perindopril; Prospective Studies; Rats; Rats, Inbred SHR; Survival Rate; Time Factors | 1997 |
Cough is common in children prescribed converting enzyme inhibitors.
Topics: Adolescent; Angiotensin-Converting Enzyme Inhibitors; Captopril; Child; Child, Preschool; Cough; Enalapril; Female; Humans; Infant; Kidney Diseases; Male; Perindopril; Time Factors | 2000 |
Endothelin, angiotensin II and adenosine in acute cyclosporine A nephrotoxicity.
Topics: Acute Disease; Adenosine; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Cyclosporine; Endothelins; Glomerular Filtration Rate; Immunosuppressive Agents; Kidney; Kidney Diseases; Male; Perindopril; Rabbits; Renal Circulation; Theophylline; Vascular Resistance; Water | 2000 |
Modulation of gentamicin nephrotoxicity by chronic inhibition of angiotensin-I-converting enzyme in rat.
Topics: Acetylglucosamine; Angiotensin-Converting Enzyme Inhibitors; Animals; Calcium; Creatinine; Cyclic AMP; Diuresis; Gentamicins; Indoles; Kidney; Kidney Cortex; Kidney Diseases; Male; Perindopril; Potassium; Rats; Rats, Inbred Strains; Sodium; Time Factors | 1989 |